chr12-102164591-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017915.5(PARPBP):āc.649C>Gā(p.Gln217Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000831 in 1,613,184 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q217H) has been classified as Uncertain significance.
Frequency
Consequence
NM_017915.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PARPBP | NM_017915.5 | c.649C>G | p.Gln217Glu | missense_variant | 5/11 | ENST00000327680.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PARPBP | ENST00000327680.7 | c.649C>G | p.Gln217Glu | missense_variant | 5/11 | 2 | NM_017915.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152042Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251208Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135764
GnomAD4 exome AF: 0.0000876 AC: 128AN: 1461142Hom.: 0 Cov.: 30 AF XY: 0.0000702 AC XY: 51AN XY: 726928
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152042Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74276
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2024 | The c.649C>G (p.Q217E) alteration is located in exon 5 (coding exon 4) of the PARPBP gene. This alteration results from a C to G substitution at nucleotide position 649, causing the glutamine (Q) at amino acid position 217 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at